Two CCR7 SNPs, CCR7 rs3136685 and CCR7 rs17708087, were identified as having an elevated risk of NSCLC compared to the wild-type gene; both CCR7 SNPs are postulated to be histone epigenetic modifiers and may represent patients at particularly high risk of developing lung cancer [218]. This evidence concerns the gene CCR7 and lung carcinoma.